{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:15:47Z","timestamp":1790874947593,"version":"4.1.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2008,6,24]],"date-time":"2008-06-24T00:00:00Z","timestamp":1214265600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharm World Sci"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1007\/s11096-008-9231-6","type":"journal-article","created":{"date-parts":[[2008,6,23]],"date-time":"2008-06-23T01:28:13Z","timestamp":1214184493000},"page":"613-616","source":"Crossref","is-referenced-by-count":9,"title":["Osteoporosis after combined use of a neuroleptic and antidepressants"],"prefix":"10.1007","volume":"30","author":[{"given":"Gert","family":"Laekeman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lieven","family":"Zwaenepoel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Reyntens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Vos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minne","family":"Casteels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,6,24]]},"reference":[{"key":"9231_CR1","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1517\/14656566.1.5.903","volume":"1","author":"PJ Goodnick","year":"2000","unstructured":"Goodnick PJ, Chaudry T, Artadi J, Arcey S. Women\u2019s issues in mood disorders. Expert Opin Pharmacother. 2000;1:903\u201316.","journal-title":"Expert Opin Pharmacother."},{"key":"9231_CR2","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/00006842-199509000-00011","volume":"57","author":"U Halbreich","year":"1995","unstructured":"Halbreich U, Rojansky N, Palter S, Hreshchyshyn M, Kreeger J, Bakhai Y, et al. Decrease bone mineral density in medicated psychiatric patients. Psychosomatic Med. 1995;57:485\u201391.","journal-title":"Psychosomstic Med"},{"issue":"(Suppl. 2)","key":"9231_CR3","first-page":"S97","volume":"30","author":"M Fric","year":"2003","unstructured":"Fric M, Laux G. Plasma prolactin level and incidence of adverse endocrinologic effects during therapy with atypical neuroleptics. Psychiatr Praxis. 2003;30(Suppl. 2):S97\u2013101.","journal-title":"Psychiatr Praxis"},{"key":"9231_CR4","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1517\/14656566.1.7.1441","volume":"1","author":"RC Love","year":"2000","unstructured":"Love RC, Nelson MW. Pharmacology and clinical experience with risperdone. Expert Opin Pharmacother. 2000;1:1441\u20131453.","journal-title":"Expert Opin Pharmacother."},{"key":"9231_CR5","first-page":"766","volume-title":"Stockley\u2019s drug interactions","author":"K Baxter","year":"2008","unstructured":"Baxter K. Stockley\u2019s drug interactions. Pharmaceutical Press: London; 2008. p. 766\u2013767."},{"key":"9231_CR6","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0165-0327(97)00086-4","volume":"46","author":"JD Amsterdam","year":"1997","unstructured":"Amsterdam JD, Garcia-Espana F, Goodman D, Hooper M, Hornig-Rohan M. Breast enlargement during chronic antidepressant therapy. J Affect Disord 1997;46:151\u20136.","journal-title":"J Affect Disord"},{"key":"9231_CR7","first-page":"88","volume":"46","author":"J Morrison","year":"2001","unstructured":"Morrison J, Remick RA, Leung M, Wrixon KJ, Bebb RA. Galactorrhea induced by paroxetine. Can J Psychiatry. 2001;46:88\u20139.","journal-title":"Can J Psychiatry"},{"issue":"2","key":"9231_CR8","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/00004850-199506000-00009","volume":"10","author":"K Otani","year":"1995","unstructured":"Otani K, Yasui N, Kaneko S, Ishida M, Ohkubo T, Osanai T, et al. Trazodone treatment increases plasma prolactin concentrations in depressed patients. Int Clin Psychopharmacol. 1995;10(2):115\u20137.","journal-title":"Int Clin Psychopharmacol."},{"key":"9231_CR9","first-page":"232","volume":"13","author":"G Copinschi","year":"1990","unstructured":"Copinschi G, Van Onderbergen A, L\u2019Hermite-Baleriaux M, Szyper M, Caufriez A, Bosson D, et al. Effects of the short-acting benzodiazepine triazolam, taken at bedtime, on circadian and sleep-related hormonal profiles in normal men. Sleep. 1990;13:232\u201344.","journal-title":"Sleep"},{"issue":"6","key":"9231_CR10","first-page":"803","volume":"27","author":"M Kopecek","year":"2006","unstructured":"Kopecek M, Bares M, Horacek J, Mohr P. Low-dose risperidone augmentation of antidepressants or anxiolytics is associated with hyperprolactinemia. Neuro Endocrinol. Lett. 2006;27(6):803\u20136.","journal-title":"Lett."},{"issue":"3","key":"9231_CR11","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s002130051171","volume":"147","author":"MG Scordo","year":"1999","unstructured":"Scordo MG, Spina E, Facciol\u00e0 G, Avenoso A, Johansson I, Dahl ML. Cytochrome P450 2D6 genotype and steady state plasma levels of risperidone and 9-hydroxyrisperidone. Psychopharmacology. 1999;147(3):300\u20135.","journal-title":"Psychopharmacology"},{"issue":"8","key":"9231_CR12","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1177\/0269881107077357","volume":"21","author":"L Wang","year":"2007","unstructured":"Wang L, Zhang AP, Fang C, Du J, Gu JF, Qin SY, et al. Serum prolactin levels, plasma risperidone levels, polymorphism of cytochrome P450 2D6 and clinical response in patients with schizophrenia. J Psychopharmacol. 2007;21(8):837\u201342.","journal-title":"J Psychopharmacol"},{"key":"9231_CR13","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1001\/archinte.167.21.2329","volume":"167","author":"F Eskandari","year":"2007","unstructured":"Eskandari F, Martinez PE, Torvik S, Phillips TM, Sternberg E, Mistry S, et al. Low bone mass in premenopausal women with depression. Arch Intern Med. 2007;167:2329\u201336.","journal-title":"Arch Intern Med."},{"key":"9231_CR14","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1080\/00207450290025833","volume":"112","author":"M Bilici","year":"2002","unstructured":"Bilici M, Cakirbay H, Guler M, Tosun M, Ulgen M, Tan U. Classical and atypical neuroleptics, and bone mineral density, in patients with schizophrenia. Int J Neurosci. 2002;112:817\u201328.","journal-title":"Int J Neurosci."},{"key":"9231_CR15","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","volume":"30","author":"CA Naranjo","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239\u201345.","journal-title":"Clin Pharmacol Ther."},{"key":"9231_CR16","doi-asserted-by":"crossref","unstructured":"Shakir SAW, Layton D. Causal application in pharmacovigilance and pharmacoepidemiology. Drug Saf. 2002;25 467\u2013471.","DOI":"10.2165\/00002018-200225060-00012"}],"container-title":["Pharmacy World & Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-008-9231-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11096-008-9231-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-008-9231-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T01:51:33Z","timestamp":1559353893000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11096-008-9231-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6,24]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["9231"],"URL":"https:\/\/doi.org\/10.1007\/s11096-008-9231-6","relation":{},"ISSN":["0928-1231","1573-739X"],"issn-type":[{"value":"0928-1231","type":"print"},{"value":"1573-739X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,6,24]]}}}